Literature DB >> 8298797

Effects of pyrimidines on the guinea-pig coronary vasculature.

A J Vials1, G Burnstock.   

Abstract

1. The effects of the pyrimidines, uridine 5'-triphosphate (UTP), thymidine 5'-triphosphate (TTP) and cytidine 5'-triphosphate (CTP), were examined in the guinea-pig coronary bed, by use of a Langendorff technique. Comparisons were made with the actions of the purines adenosine 5'-triphosphate (ATP), inosine 5'-triphosphate (ITP) and guanosine 5'-triphosphate (GTP). The effect of, the nitric oxide synthase inhibitor, L-NG-nitroarginine methyl ester (L-NAME) and, the prostaglandin synthesis inhibitor, indomethacin on the vasodilator response to these purines and pyrimidines was examined. The effects of these inhibitors were assessed on their ability to inhibit both the amplitude and the area of the vasodilator response. 2. The relative order of potency of the purines and pyrimidines studied was ATP > UTP > ITP >> GTP, TTP, CTP. 3. The maximum amplitude and area of the vasodilator response to the pyrimidines, UTP (5 x 10(-10)-5 x 10(-7) mol), TTP (5 x 10(-8)-5 x 10(-7) mol) and CTP (5 x 10(-7) mol), and purines, ITP (5 x 10(-9)-5 x 10(-7) mol) and GTP (5 x 10(-8)-5 x 10(-7) mol), were significantly reduced by L-NAME (3 x 10(-5) and 10(-4) M). 4. The inhibition of the response to ATP (5 x 10-8 mol), UTP (5 x 10-8 mol), ITP (5 x 10-8 mol), TTP(5 x 10-7 mol), CTP (5 x 10- mol) and GTP (5 x 10- mol) by L-NAME (3 x 10-5 M) was significantly reversed by L-arginine (1.5 x 10-3 M).5. L-NAME (3 x 10-5 and 10-4 M) only inhibited the amplitude of the vasodilator response to a low dose of ATP (5 x 10-mol), although the area of vasodilator response to ATP(5 x 10-11-5 x 10-7 mol) was significantly reduced by L-NAME (3 x 10-5 and 10-4 M).6. The maximum amplitude of the vasodilator response to ATP (5 x 10-10-5 x 10-7 mol) was significantly reduced by indomethacin (10-6 M), although the area of the vasodilator response to ATP was only significantly reduced at one intermediate dose (5 x 10-9 mol). Indomethacin (10-6 M) did not affect the maximum amplitude or area of the vasodilator responses to UTP (5 x 10-11-5 x 10-7 mol),ITP (5 x 10-10-5 x 10-7 mol), CTP (5 x 10-7 mol), TTP (5 x 10-8-5 x 10-7 mol) and GTP(5 x 10-8-5 x 10-7 mol).7. It is concluded that in the guinea-pig coronary vasculature, the vasodilatation evoked by the pyrimidines, UTP, TTP and CTP, was mediated in large part via nitric oxide, as were the vasodilatations evoked by the purines ITP and GTP. The vasodilatations evoked by ATP, however, appear to involve prostanoids in addition to the release of nitric oxide.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8298797      PMCID: PMC2175825          DOI: 10.1111/j.1476-5381.1993.tb13926.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  37 in total

1.  Biosynthesis of endothelium-derived relaxing factor: a cytosolic enzyme in porcine aortic endothelial cells Ca2+-dependently converts L-arginine into an activator of soluble guanylyl cyclase.

Authors:  B Mayer; K Schmidt; P Humbert; E Böhme
Journal:  Biochem Biophys Res Commun       Date:  1989-10-31       Impact factor: 3.575

2.  A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells.

Authors:  R M Palmer; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1989-01-16       Impact factor: 3.575

3.  Adenosine 5'-triphosphate, adenosine and endothelium-derived relaxing factor in hypoxic vasodilatation of the heart.

Authors:  A M Hopwood; J Lincoln; K A Kirkpatrick; G Burnstock
Journal:  Eur J Pharmacol       Date:  1989-06-20       Impact factor: 4.432

4.  Stimulation of prostacyclin release from aortic smooth muscle cells by purine and pyrimidine nucleotides.

Authors:  D Demolle; C Lagneau; J M Boeynaems
Journal:  Eur J Pharmacol       Date:  1988-10-18       Impact factor: 4.432

5.  Stimulation of thromboxane release by extracellular UTP and ATP from perfused rat liver. Role of icosanoids in mediating the nucleotide responses.

Authors:  D Häussinger; E Busshardt; T Stehle; B Stoll; M Wettstein; W Gerok
Journal:  Eur J Biochem       Date:  1988-12-01

6.  Kinetics of adenine nucleotide catabolism in coronary circulation of rats.

Authors:  G Fleetwood; S B Coade; J L Gordon; J D Pearson
Journal:  Am J Physiol       Date:  1989-06

7.  Arginine is a physiological precursor of endothelium-derived nitric oxide.

Authors:  H H Schmidt; H Nau; W Wittfoht; J Gerlach; K E Prescher; M M Klein; F Niroomand; E Böhme
Journal:  Eur J Pharmacol       Date:  1988-09-13       Impact factor: 4.432

8.  ATP mediates coronary vasoconstriction via P2x-purinoceptors and coronary vasodilatation via P2y-purinoceptors in the isolated perfused rat heart.

Authors:  A M Hopwood; G Burnstock
Journal:  Eur J Pharmacol       Date:  1987-04-07       Impact factor: 4.432

9.  Endothelium-dependent relaxation by uridine tri- and diphosphate in isolated human pial vessels.

Authors:  J E Hardebo; J Kåhrström; C Owman; L G Salford
Journal:  Blood Vessels       Date:  1987

10.  L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation.

Authors:  R M Palmer; D D Rees; D S Ashton; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1988-06-30       Impact factor: 3.575

View more
  4 in total

1.  The effects of purine compounds on the isolated aorta of the frog Rana temporaria.

Authors:  G E Knight; G Burnstock
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

2.  Intravascular ATP and coronary vasodilation in the isolated working rat heart.

Authors:  O Korchazhkina; G Wright; C Exley
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

3.  Evidence for a P2-purinoceptor mediating vasoconstriction by UTP, ATP and related nucleotides in the isolated pulmonary vascular bed of the rat.

Authors:  A Rubino; G Burnstock
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

4.  Evidence for a discrete UTP receptor in cardiac endothelial cells.

Authors:  S Yang; I L Buxton; C B Probert; J N Talbot; M E Bradley
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.